Novocure: HC Wainwright Keeps Buy Rating, Lowers PT to $39.

martes, 13 de enero de 2026, 7:47 am ET1 min de lectura
NVCR--

Novocure: HC Wainwright Keeps Buy Rating, Lowers PT to $39.

Novocure: HC Wainwright Keeps Buy Rating, Lowers PT to $39.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios